Literature DB >> 17133552

Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.

I-Jen Wang1, Li-Ming Huang, Hsiu-Hsi Chen, Kung-Chang Hwang, Chien-Jen Chen.   

Abstract

Rubella vaccination was implemented nationwide in 1992 in Taiwan. A cross-sectional survey was conducted to determine the age-specific seroprevalence of anti-rubella in female students aged 7-22 years old and women of reproductive age in Taipei County. Seropositivity of anti-rubella antibodies was defined as a serum IgG level > or =10 IU/ml tested by enzyme immunoassay. Information on possible predictors of anti-rubella seronegativity was obtained from structured questionnaire interview. Multivariate-adjusted odds ratios (ORm) with their 95% confidence interval (CI) were derived for each predictor using multiple logistic regression analysis. A total of 826 female students and 318 women were recruited. Anti-rubella seropositive rates were 98.3% (282/287), 99.6% (234/235), 96.8% (179/185), 92.4% (110/119), 81.4% (197/242), and 89.5% (68/76) for the age groups of 7-9, 11-13, 15-17, 19-22, 25-33, and 34-44 years old, respectively. Among female students, negative serology for rubella antibodies was associated significantly with the age group and foreign nationality of mother, showing ORm (95% CI) of 1.2 (1.06-1.27) for each year increase in age, and 20.9 (6.31-68.97), respectively. Among women at the reproductive age, low maternal education level 91.6 (9.12-920.74), unmarried status 21.2 (6.16-72.89), and no rubella vaccination 98.9 (11.64-840.25) were associated significantly with an increased evidence of seronegativity to rubella. The National Rubella Vaccination Program has led to herd immunity of school girls. However, in order to eradicate the Rubella syndrome, greater effort is required to vaccinate foreign brides in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133552     DOI: 10.1002/jmv.20764

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Persistence and titer changes of rubella virus antibodies in primiparous women who had been vaccinated with strain RA 27/3 in junior high school.

Authors:  Ching-Chiang Lin; Chun-Yuh Yang; Yung-Luen Shih; Yang-Yang Huang; Tsung-Han Yang; Jin-Yuan Liang; Chu-Fen Chang; Hsiu-Shu Hsieh; Yeou-Lih Huang
Journal:  Clin Vaccine Immunol       Date:  2011-11-09

2.  Congenital rubella syndrome: the end is in sight.

Authors:  Scott R Lambert
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

3.  Epidemiologic features of mumps in Taiwan from 2006 to 2011: a new challenge for public health policy.

Authors:  Chian-Ching Chen; Chien-Chih Lu; Bo-Hua Su; Kow-Tong Chen
Journal:  World J Pediatr       Date:  2014-11-22       Impact factor: 2.764

4.  Rubella seroepidemiology and catch-up immunization among pregnant women in Taiwan: comparison between women born in Taiwan and immigrants from six countries in Asia.

Authors:  Ching-Chiang Lin; Chun-Yuh Yang; Ching-Tang Shih; Bai-Hsiun Chen; Yeou-Lih Huang
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

Review 5.  Preconception care: preventing and treating infections.

Authors:  Zohra S Lassi; Ayesha M Imam; Sohni V Dean; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

6.  Phylogeography of rubella virus in Asia: Vaccination and demography shape synchronous outbreaks.

Authors:  Brooke A Bozick; Colin J Worby; C Jessica E Metcalf
Journal:  Epidemics       Date:  2019-05-28       Impact factor: 4.396

7.  How useful is a history of rubella vaccination for determination of disease susceptibility? A cross-sectional study at a public funded health clinic in Malaysia.

Authors:  Ai Theng Cheong; Seng Fah Tong; Ee Ming Khoo
Journal:  BMC Fam Pract       Date:  2013-01-31       Impact factor: 2.497

Review 8.  Born too soon: care before and between pregnancy to prevent preterm births: from evidence to action.

Authors:  Sohni V Dean; Elizabeth Mason; Christopher P Howson; Zohra S Lassi; Ayesha M Imam; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2013-11-15       Impact factor: 3.223

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.